Assessment of diabetic retinopathy by measuring retina-specific mRNA in blood. (Q49177421)

18 February 2018

title

Assessment of diabetic retinopathy by measuring retina-specific mRNA in blood. (English)

1 reference

18 February 2018

1 reference

A Butt

1

1 reference

18 February 2018

M S Ahmad

series ordinal

2

1 reference

18 February 2018

J Powrie

series ordinal

3

1 reference

18 February 2018

R Swaminathan

series ordinal

4

1 reference

18 February 2018

language of work or name

English

0 references

publication date

18 May 2012

1 reference

18 February 2018

Expert Opinion on Biological Therapy

published in

1 reference

18 February 2018

volume

12 Suppl 1

1 reference

18 February 2018

page(s)

S79-84

1 reference

18 February 2018

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.688947

Grading and disease management in national screening for diabetic retinopathy in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.688947

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.688947

The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.688947

Screening and prevention of diabetic blindness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.688947

The impact of national diabetic retinopathy screening on ophthalmology: the need for urgent planning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.688947

Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.688947

Prenatal diagnosis: progress through plasma nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.688947

Cell-free plasma DNA as a prognostic marker in intensive treatment unit patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.688947

Measurement of thyroglobulin mRNA in peripheral blood as an adjunctive test for monitoring thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.688947

Human retina-specific amine oxidase (RAO): cDNA cloning, tissue expression, and chromosomal mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.688947

Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.688947

Stability of beta-actin mRNA in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.688947

Illegitimate transcription: transcription of any gene in any cell type

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.688947

Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.688947

10.1517/14712598.2012.688947

21 January 2018

Identifiers

DOI

1 reference

18 February 2018

PubMed ID

22594562

1 reference

18 February 2018